BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 31408176)

  • 1. Hepatic Fatty Acid Balance and Hepatic Fat Content in Humans With Severe Obesity.
    Lytle KA; Bush NC; Triay JM; Kellogg TA; Kendrick ML; Swain JM; Gathaiya NW; Hames KC; Jensen MD
    J Clin Endocrinol Metab; 2019 Dec; 104(12):6171-6181. PubMed ID: 31408176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipocyte Proteins and Storage of Endogenous Fatty Acids in Visceral and Subcutaneous Adipose Tissue in Severe Obesity.
    Lytle KA; Bush NC; Triay JM; Kellogg TA; Kendrick ML; Swain JM; Gathaiya NW; Hames KC; Jensen MD
    Obesity (Silver Spring); 2021 Jun; 29(6):1014-1021. PubMed ID: 33893721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating very-low-density lipoprotein characteristics resulting from fatty liver in an insulin resistance rat model.
    Zago V; Lucero D; Macri EV; Cacciagiú L; Gamba CA; Miksztowicz V; Berg G; Wikinski R; Friedman S; Schreier L
    Ann Nutr Metab; 2010; 56(3):198-206. PubMed ID: 20203480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thioesterase Superfamily Member 2 Promotes Hepatic VLDL Secretion by Channeling Fatty Acids Into Triglyceride Biosynthesis.
    Alves-Bezerra M; Li Y; Acuña M; Ivanova AA; Corey KE; Ortlund EA; Cohen DE
    Hepatology; 2019 Aug; 70(2):496-510. PubMed ID: 30516845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease.
    Fabbrini E; Mohammed BS; Magkos F; Korenblat KM; Patterson BW; Klein S
    Gastroenterology; 2008 Feb; 134(2):424-31. PubMed ID: 18242210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S-Adenosylmethionine increases circulating very-low density lipoprotein clearance in non-alcoholic fatty liver disease.
    Martínez-Uña M; Varela-Rey M; Mestre D; Fernández-Ares L; Fresnedo O; Fernandez-Ramos D; Gutiérrez-de Juan V; Martin-Guerrero I; García-Orad A; Luka Z; Wagner C; Lu SC; García-Monzón C; Finnell RH; Aurrekoetxea I; Buqué X; Martínez-Chantar ML; Mato JM; Aspichueta P
    J Hepatol; 2015 Mar; 62(3):673-81. PubMed ID: 25457203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis.
    Lee JJ; Lambert JE; Hovhannisyan Y; Ramos-Roman MA; Trombold JR; Wagner DA; Parks EJ
    Am J Clin Nutr; 2015 Jan; 101(1):34-43. PubMed ID: 25527748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex-Specific Differences in Hepatic Fat Oxidation and Synthesis May Explain the Higher Propensity for NAFLD in Men.
    Pramfalk C; Pavlides M; Banerjee R; McNeil CA; Neubauer S; Karpe F; Hodson L
    J Clin Endocrinol Metab; 2015 Dec; 100(12):4425-33. PubMed ID: 26414963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.
    Calvo N; Beltrán-Debón R; Rodríguez-Gallego E; Hernández-Aguilera A; Guirro M; Mariné-Casadó R; Millá L; Alegret JM; Sabench F; del Castillo D; Vinaixa M; Rodríguez MÀ; Correig X; García-Álvarez R; Menendez JA; Camps J; Joven J
    World J Gastroenterol; 2015 Jun; 21(24):7529-44. PubMed ID: 26140000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Greater dietary fat oxidation in obese compared with lean men: an adaptive mechanism to prevent liver fat accumulation?
    Hodson L; McQuaid SE; Humphreys SM; Milne R; Fielding BA; Frayn KN; Karpe F
    Am J Physiol Endocrinol Metab; 2010 Oct; 299(4):E584-92. PubMed ID: 20628024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Menopausal Status and Abdominal Obesity Are Significant Determinants of Hepatic Lipid Metabolism in Women.
    Hodson L; Banerjee R; Rial B; Arlt W; Adiels M; Boren J; Marinou K; Fisher C; Mostad IL; Stratton IM; Barrett PH; Chan DC; Watts GF; Harnden K; Karpe F; Fielding BA
    J Am Heart Assoc; 2015 Oct; 4(10):e002258. PubMed ID: 26432801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schizandrin A supplementation improves nonalcoholic fatty liver disease in mice fed a high-fat and high-cholesterol diet.
    Jeong MJ; Kim SR; Jung UJ
    Nutr Res; 2019 Apr; 64():64-71. PubMed ID: 30802724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity.
    Riches FM; Watts GF; Naoumova RP; Kelly JM; Croft KD; Thompson GR
    Int J Obes Relat Metab Disord; 1998 May; 22(5):414-23. PubMed ID: 9622338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein subclass metabolism in nonalcoholic steatohepatitis.
    Männistö VT; Simonen M; Soininen P; Tiainen M; Kangas AJ; Kaminska D; Venesmaa S; Käkelä P; Kärjä V; Gylling H; Ala-Korpela M; Pihlajamäki J
    J Lipid Res; 2014 Dec; 55(12):2676-84. PubMed ID: 25344588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic lipid composition and stearoyl-coenzyme A desaturase 1 mRNA expression can be estimated from plasma VLDL fatty acid ratios.
    Peter A; Cegan A; Wagner S; Lehmann R; Stefan N; Königsrainer A; Königsrainer I; Häring HU; Schleicher E
    Clin Chem; 2009 Dec; 55(12):2113-20. PubMed ID: 19850634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise increases myocardial free fatty acid oxidation in subjects with metabolic dysfunction-associated fatty liver disease.
    Risikesan J; Heebøll S; Kumarathas I; Funck KL; Søndergaard E; Johansen RF; Ringgaard S; Tolbod LP; Johannsen M; Kanstrup HL; Grønbæk H; Frystyk J; Gormsen LC; Nielsen S
    Atherosclerosis; 2023 May; 372():10-18. PubMed ID: 37011565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic-associated fatty liver disease and lipoprotein metabolism.
    Heeren J; Scheja L
    Mol Metab; 2021 Aug; 50():101238. PubMed ID: 33892169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No effect of resveratrol on VLDL-TG kinetics and insulin sensitivity in obese men with nonalcoholic fatty liver disease.
    Poulsen MK; Nellemann B; Bibby BM; Stødkilde-Jørgensen H; Pedersen SB; Grønbaek H; Nielsen S
    Diabetes Obes Metab; 2018 Oct; 20(10):2504-2509. PubMed ID: 29885082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma lipoproteins and regulation of hepatic metabolism of fatty acids in altered thyroid states.
    Heimberg M; Olubadewo JO; Wilcox HG
    Endocr Rev; 1985; 6(4):590-607. PubMed ID: 3908084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.